BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
0.2228
-0.0052 (-2.28%)
At close: Apr 23, 2026, 4:00 PM EDT
0.2167
-0.0061 (-2.74%)
After-hours: Apr 23, 2026, 4:48 PM EDT

BioRestorative Therapies Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6101081015
Market Cap Growth
-55.65%5.40%20.82%-19.02%-33.80%-22.64%
Enterprise Value
2.97.49-0.82-2.86-4.46-5.24
Last Close Price
0.221.181.431.742.754.34
PE Ratio
--0.74-1.23-0.70-0.75-0.12
PS Ratio
16.1529.0024.6856.1784.42332.14
PB Ratio
5.900.060.060.820.980.71
P/TBV Ratio
0.010.060.070.730.970.24
P/FCF Ratio
--0.96-1.19-1.24-1.64-4.55
P/OCF Ratio
--0.97-1.20-1.27-1.71-4.59
EV/Sales Ratio
8.0620.82-2.05-19.63-37.21-113.92
EV/EBITDA Ratio
--0.470.070.190.230.20
EV/EBIT Ratio
--0.470.070.190.230.20
EV/FCF Ratio
--0.690.100.430.721.56
Debt / Equity Ratio
-0000.020.02
Debt / EBITDA Ratio
----0.01-0.02-0.03
Debt / FCF Ratio
----0.02-0.05-0.20
Net Debt / Equity Ratio
-0.02-0.02-0.06-1.09-1.40-0.94
Net Debt / EBITDA Ratio
0.190.190.910.720.760.78
Net Debt / FCF Ratio
0.270.271.291.652.346.06
Asset Turnover
0.040.040.030.010.010.00
Quick Ratio
0.800.802.914.252.4757.81
Current Ratio
0.840.842.974.372.5359.01
Return on Equity (ROE)
-7.88%-7.88%-7.78%-56.77%-191.91%95.11%
Return on Assets (ROA)
-195.40%-195.40%-95.84%-105.81%-98.20%-196.67%
Return on Invested Capital (ROIC)
3644.19%3644.19%-2473.94%-1514.72%-1454.64%-3219.89%
Return on Capital Employed (ROCE)
-359.65%-359.65%-128.70%-150.23%-117.35%-207.58%
Earnings Yield
-245.17%-134.47%-81.12%-141.95%-132.73%-859.45%
FCF Yield
-187.73%-104.56%-84.25%-80.60%-61.09%-22.00%
Buyback Yield / Dilution
-15.83%-15.83%-84.05%-16.60%-204.60%-200.92%
Total Shareholder Return
-15.83%-15.83%-84.05%-16.60%-204.60%-200.92%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q